Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations., PMID:39202532
Expression Analysis of SSTR 1, 2 and 3 in Small-cell Lung Cancer Patients as Targets for Future Peptide Receptor Radionuclide Therapy., PMID:39197921
Expression of somatostatin receptors in canine and feline meningioma., PMID:39011594
A targeting nanoplatform for chemo-photothermal synergistic therapy of small-cell lung cancer., PMID:38985144
Chemokine Receptor CXCR4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers., PMID:37989124
Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment., PMID:37716507
Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions., PMID:37707798
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas., PMID:37444563
A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience., PMID:37185426
Immunohistochemical somatostatin receptor expression in insulinomas., PMID:36680557
SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity., PMID:36463361
Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study., PMID:36362289
Correlation of Somatostatin Receptor 2 Expression, 68Ga-DOTATATE PET Scan and Octreotide Treatment in Thymic Epithelial Tumors., PMID:35198446
Correlation of Somatostatin Receptor 1-5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms., PMID:35008325
Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children., PMID:34497584
Antibody-Drug Conjugate to Treat Meningiomas., PMID:34063284
Necrosis binding of Ac-Lys0(IRDye800CW)-Tyr3-octreotate: a consequence from cyanine-labeling of small molecules., PMID:33970376
Drug Development in Neuroendocrine Tumors: What Is on the Horizon?, PMID:33786683
Somatostatin receptors in normal and acromegalic somatotroph cells: the U-turn of the clinician to immunohistochemistry report - a review., PMID:33544787
Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment., PMID:33187322
Anti-SSTR2 antibody-drug conjugate for neuroendocrine tumor therapy., PMID:32684623
Somatostatin receptors (SSTR1-5) on inhibitory interneurons in the barrel cortex., PMID:31873798
Somatostatin Type 2 Receptor Antibody Enhances Mechanical Hyperalgesia in the Dorsal Root Ganglion Neurons after Sciatic Nerve-pinch Injury: Evidence of Behavioral Studies and Bax Protein Expression., PMID:31686636
Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer., PMID:31649014
A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor-guided antibody-drug conjugate: Perspectives on clinical response?, PMID:31543319
Somatostatin receptor 2 targeting in small cell lung carcinoma: perspectives., PMID:31413814
Immunohistochemical Expression of Somatostatin Receptor Subtypes in a Panel of Neuroendocrine Neoplasias., PMID:31381461
Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo., PMID:30735385
Somatostatin Receptor Expression Is Associated With Metastasis and Patient Outcome in Pulmonary Carcinoid Tumors., PMID:30657933
Pathological markers of somatotroph pituitary neuroendocrine tumors predicting the response to medical treatment., PMID:30531694
Immunohistochemical Analysis of Somatostatin Receptors in Endometriosis Tissue Samples: A Retrospective Study., PMID:29750706
Expression of growth hormone gene in the baboon eye., PMID:29407222
Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets., PMID:29282035
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs., PMID:29180250
Immunohistochemical evaluation of molecular radiotherapy target expression in neuroblastoma tissue., PMID:29043399
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma., PMID:28948577
Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues., PMID:28396686
Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining., PMID:28182792
Expression of somatostatin receptors 2 and 5 in circulating tumour cells from patients with neuroendocrine tumours., PMID:27875519
[Somatostatin receptor expression in the ileal mucosa of patients with inflammatory bowel disease]., PMID:26978232
Immunochemical strategy for quantification of G-coupled olfactory receptor proteins on natural nanovesicles., PMID:26724468
Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines., PMID:25925002
Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity., PMID:25765179
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16., PMID:25683115
Expression and localization of somatostatin receptor types 3, 4 and 5 in the wild-type, SSTR1 and SSTR1/SSTR2 knockout mouse cochlea., PMID:25149275
Cytoplasmic expression of SSTR2 and 5 by immunohistochemistry and by RT/PCR is not associated with the pharmacological response to octreotide., PMID:25008035
Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel., PMID:24393170
Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice., PMID:23958249
Correlation of immunohistopathological expression of somatostatin receptor-2 in breast cancer and tumor detection with 68Ga-DOTATOC and 18F-FDG PET imaging in an animal model., PMID:23898054
Zoledronic acid but not somatostatin analogs exerts anti-tumor effects in a model of murine prostatic neuroendocrine carcinoma of the development of castration-resistant prostate cancer., PMID:22996996
For research use only. Not for human or drug use.
